| Outcomes of Patients With Osteopetrosis Weight-bearing Bone Fractures (NCT06521580) | Kasr El Aini Hospital | 2022-01-01 |
| ACTIMMUNE in Intermediate Osteopetrosis (NCT02666768) | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center | 2016-02-22 |
| Study of Gene Modified Donor T-cells Following TCR Alpha Beta Positive Depleted Stem Cell Transplant (NCT03301168) | Bellicum Pharmaceuticals | 2014-04-01 |
| Longitudinal Study of Neurodegenerative Disorders (NCT03333200) | University of Pittsburgh | 2012-01-11 |
| Hematopoietic Stem Cell Transplantation for Malignant Infantile Osteopetrosis (NCT01087398) | Tehran University of Medical Sciences | 2009-09-01 |
| T-cell Depleted Alternative Donor Transplantation (NCT00968864) | Wake Forest University Health Sciences | 2009-08-01 |
| Clinical Assessment of Patients With High Bone Mass Due to Mutation in Lrp5 (NCT01199094) | Odense University Hospital | 2009-01-01 |
| Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells (NCT00730314) | Children's Hospital Los Angeles | 2008-08-01 |
| Reduced Intensity AlloTransplant For Osteopetrosis (NCT00638820) | Masonic Cancer Center, University of Minnesota | 2007-09-01 |
| Stem Cell Transplantation for Children Affected With Osteopetrosis (NCT00145587) | St. Jude Children's Research Hospital | 2004-07-01 |
| rhPTH Therapy for Low Turnover Bone Fragility (NCT00145886) | University of Chicago | 2003-02-01 |
| Risk-Adapted Allogeneic Stem Cell Transplantation For Mixed Donor Chimerism In Patients With Non-Malignant Diseases (NCT01019876) | Columbia University | 2002-09-01 |
| Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis (NCT00043329) | InterMune | 2002-01-01 |
| Phase III Randomized Study of Interferon Gamma in Children With Severe, Congenital Osteopetrosis (NCT00004402) | FDA Office of Orphan Products Development | 1999-11-01 |
| Expanded Access Protocol (EAP) Using the CliniMACS® Device for Pediatric Haplocompatible Donor Stem Cell Transplant (NCT01200017) | Christopher Dvorak | |